© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
Conversations in Critical Psychiatry
The Fight for Pharma Accountability and Psychiatric Rights: Jim Gottstein, Esq
August 02, 2022
A lawyer weighs in on pharmaceutical corruption and involuntary psychiatric care.
The Biocognitive Model for Biopsychosocial Psychiatry: Niall McLaren, MBBS, FRANZCP
June 30, 2022
Does a computational approach to the mind pave the way for practicing a biopsychosocial psychiatry?
Neurodiversity and the Social Ecology of Disability
May 23, 2022
“This model challenges the idea that many neurodivergent individuals necessarily have neurological or cognitive pathologies, as well as the idea that neurotypicals are necessarily superior...”
Upon the Shores of Social Construction
April 15, 2022
Sami Timimi, MD, shares his thoughts on alienation and ADHD, and what role current systems of mental health play.
What Can Philosophy Learn From Madness?
January 19, 2022
Wouter Kusters, PhD, uses his experiences with psychosis to better inform his philosophy. What can we learn from him?
Traveling the Middle Road Between Skepticism and Scientism
October 21, 2021
What is the real-world clinical efficacy of SSRIs and other antidepressant medications compared to RCT placebos?
The Neurodiversity Paradigm in Psychiatry: Robert Chapman, PhD
September 24, 2021
Is neurodivergence to be cured or is it a healthy part of our social ecology?
Trauma and the Politics of Diagnosis: Janice Haaken, PhD
July 13, 2021
How should the sociopolitical nature of PTSD as a diagnosis inform our understanding of trauma?
From Classic and Critical to Integrative Psychiatry: Dan J. Stein, MD, PhD, DPhil
July 01, 2021
Travelling the middle road between skepticism and scientism in psychiatric research and treatment.